QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
LON:SNG

Synairgen (SNG) Share Forecast, Price & News

GBX 8.40
-0.54 (-6.04%)
(As of 06/1/2023 ET)
Compare
Today's Range
8.39
9.49
50-Day Range
7.43
16.50
52-Week Range
7.01
36.48
Volume
115,932 shs
Average Volume
504,610 shs
Market Capitalization
£16.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SNG stock logo

About Synairgen (LON:SNG) Stock

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Receive SNG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synairgen and its competitors with MarketBeat's FREE daily newsletter.

SNG Stock News Headlines

Synairgen (LON:SNG) Reaches New 52-Week Low at $7.01
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Synairgen (LON:SNG) Sets New 12-Month Low at $7.01
Companies Like Synairgen (LON:SNG) Could Be Quite Risky
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Can Synairgen (LON:SNG) Afford To Invest In Growth?
See More Headlines

SNG Price History

SNG Company Calendar

Last Earnings
9/29/2020
Today
6/01/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Net Income
£-17,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£79,000.00
Cash Flow
GBX 4.43 per share
Book Value
GBX 10 per share

Miscellaneous

Free Float
N/A
Market Cap
£16.92 million
Optionable
Not Optionable
Beta
-2.27

Key Executives

  • Mr. Richard Marsden (Age 54)
    CEO, MD & Exec. Director
    Comp: $1.02M
  • Prof. Stephen T. Holgate CBE (Age 74)
    M.D., Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board
    Comp: $30k
  • Mr. John Ward (Age 60)
    CFO & Exec. Director
    Comp: $887k
  • Dr. Phillip David Monk (Age 53)
    Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director
    Comp: $758k
  • Prof. Donna Davies
    Co-Founder & Member of Scientific Advisory Board
  • Prof. Ratko Djukanovic
    Co-Founder & Member of Scientific Advisory Board
  • Ms. Brooke S Clarke
    Sr. VP & Head of Communications
  • Dr. Gareth E. Walters Ph.D. (Age 63)
    Chief Regulatory Officer
  • Ms. Jody Brookes
    Sr. VP & Head of Clinical Operations
  • Mr. Richard Hennings (Age 52)
    Chief Commercial Officer













SNG Stock - Frequently Asked Questions

How have SNG shares performed in 2023?

Synairgen's stock was trading at GBX 13.50 at the start of the year. Since then, SNG shares have decreased by 37.8% and is now trading at GBX 8.40.
View the best growth stocks for 2023 here
.

How were Synairgen's earnings last quarter?

Synairgen plc (LON:SNG) posted its quarterly earnings results on Tuesday, September, 29th. The company reported ($3.11) earnings per share for the quarter.

What other stocks do shareholders of Synairgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Alibaba Group (BABA), Yamana Gold (YRI), Eldorado Gold (ELD), Ocado Group (OCDO), Polo Resources (POL), Silvercorp Metals (SVM), W Resources (WRES), Associated British Foods (ABF), Ariana Resources (AAU) and First Majestic Silver (AG).

What is Synairgen's stock symbol?

Synairgen trades on the London Stock Exchange (LON) under the ticker symbol "SNG."

How do I buy shares of Synairgen?

Shares of SNG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Synairgen's stock price today?

One share of SNG stock can currently be purchased for approximately GBX 8.40.

How much money does Synairgen make?

Synairgen (LON:SNG) has a market capitalization of £16.92 million and generates £79,000.00 in revenue each year. The company earns £-17,640,000.00 in net income (profit) each year or GBX (0.08) on an earnings per share basis.

How can I contact Synairgen?

Synairgen's mailing address is Southampton General Hosp, Tremona Road, SOUTHAMPTON, SO16 6YD, United Kingdom. The official website for the company is www.synairgen.com. The company can be reached via phone at +44-23-80512800.

This page (LON:SNG) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -